baber/WOPTO huggingface dataset:
Patent EP-0745198-B1 (EP)
Inventor: TOLKSDORF DETLEF
IPC: F16H47/04
Filed: 1995-02-09
Granted: 1998-08-12
Abstract: PCT No. PCT/EP95/00470 Sec. 371 Date Mar. 18, 1996 Sec. 102(e) Date Mar. 18, 1996 PCT Filed Feb. 9, 1995 PCT Pub. No. WO95/22704 PCT Pub. Date Aug. 24, 1995A hydrostatic transmission has at least one pump, first and second motors connected to and driven by the pump and having respective first and second motor shafts, and a planetary-gear drive. This drive has a sun gear connected permanently to the first motor shaft, planet gears in mesh with the sun gear, a planet carrier carrying the planet gears and forming an output, and a ring gear meshing with the planet gears. First gearing and a first clutch are connected between the motor shafts and a brake connected to the ring gear is actuatable to arrest same. A second clutch is connected between the second motor shaft and the ring gear. In a first range the first clutch is closed, the second clutch is opened, and the brake is actuated to drive the sun gear with both shafts with the ring gear stopped. In a second range the first clutch is opened, the second clutch is closed, and the brake is released to drive the sun gear with the one shaft and the ring gear with the other shaft.
Patent EP-0758885-B1 (EP)
Inventor: HOFFMANN HANS-RAINER
IPC: A61K9/70
Filed: 1995-05-08
Granted: 2000-12-06
Abstract: A device for the release of substances from pressure sensitive hot-melt adhesives with a uniform or non-uniform distribution of said substances is characterized by the fact that the pressure sensitive hot-melt adhesive is hydrophilic and comprises at least one water-soluble, or at least water-swellable, polymer, at least one water-soluble, meltable adhesive resin, as well as substance to be released.
Patent EP-0760871-B1 (EP)
Title: Process for coating phosphatized metal substrates
Inventor: BUETTNER GABRIELE
IPC: C23C22/83
Filed: 1995-05-23
Granted: 1998-05-06
Abstract: PCT No. PCT/EP95/01957 Sec. 371 Date Feb. 26, 1997 Sec. 102(e) Date Feb. 26, 1997 PCT Filed May 23, 1995 PCT Pub. No. WO95/33083 PCT Pub. Date Dec. 7, 1995A process for coating phosphated metal substrates with one or more organic coatings, in which after phosphating and before application of a first organic coating, the phosphated metal substrates are treated with an aqueous solution which contains 5 to 10000 ppm of dissolved titanium, vanadium, molybdenum, silver, tin, antimony and/or one or more elements of atomic numbers 57 to 83 in the form of inorganic and/or organic compounds, wherein the phosphated metal substrates are additionally connected as a cathode during the entire treatment or for part of the duration of the treatment.
Patent EP-0765321-B1 (EP)
Inventor: GODFREY ALEXANDER GLENN
IPC: C07D413/12
Filed: 1995-06-07
Granted: 2001-04-18
Abstract: A group of 2-amino-3-aroyl-benzo[ beta ]thiophenes are prepared by treating an aldehyde with an anion of dimethylamino thioformamide, cyclizing the  alpha -hydroxy thioamide, and subsequently acylating the benzo[ beta ]thiophene to yield the 2-amino-3-aryl derivative. These compounds may be treated with suitable phenyl Grignard reagents, and after deprotection, yield 6-hydroxy-2-(4-hydroxyphenyl)-3-[4-(2-piperidinoethoxy)benzoyl]benzo[ beta ]thiophene.
Patent EP-0782625-B1 (EP)
Inventor: LO KIN-MING
IPC: C07K14/16
Filed: 1995-09-14
Granted: 2007-05-09
Abstract: Disclosed are DNAs produced by recombinant techniques for inducing the expression and subsequent secretion of a target protein. The DNAs encode, in their 5' to 3' direction, a secretion cassette, including a signal sequence and an immunoglobulin Fc region, and a target protein. The DNAs can be transfected into a host cell for the expression, production and subsequent secretion of the target protein as a fusion protein. The secreted protein can be collected from the extracellular space, and further purified as desired. The secreted fusion protein additionally can be proteolytically cleaved to release the target protein from the secretion cassette.
Patent EP-0793484-B1 (EP)
Inventor: HAENSLER JEAN
IPC: A61K9/127
Filed: 1995-11-14
Granted: 2003-02-19
Abstract: An amphipathic compound including a sterol-derived lipophilic grouping bound to a cationic grouping for use as an adjuvant in the delivery of a vaccine composition. In a particular embodiment, the lipophilic grouping is a cholesterol derivative and the cationic grouping is a quaternary ammonium or a protonatable amine. A vaccine composition including one or more antigens with at least one amphipathic compound having a sterol-derived lipophilic grouping bound to a cationic grouping, is also disclosed.
Patent EP-0796544-B1 (EP)
Inventor: CHAMBERT GEORGE
IPC: H04B7/06
Filed: 1995-11-22
Granted: 2004-02-04
Abstract: La présente invention concerne un système numérique cellulaire mobile de radiocommunications, comprenant une station mobile (MS) qui transmet un bloc d'informations, et un ensemble de stations de base (BS1, BS2) qui reçoivent des blocs d'informations (BL1, BL2) correspondant audit bloc d'informations transmis, à chaque station de base de l'ensemble mentionné. Ce système de communications comprend un système de macrodiversité en voie montante, avec dans chaque station de base (BS1, BS2) des moyens (MPC1, MPC2) pour déterminer une mesure de qualité (Q1, Q2) représentant la fiabilité de chaque bloc d'informations reçu considéré (BL1, BL2), et des moyens de décision (DEC) servant à choisir le bloc d'informations reçu (BL1, BL2) présentant la meilleure mesure de qualité, en tant que bloc d'informations de sortie commun de l'ensemble mentionné de stations de base (BS1, BS2).
Patent EP-0777957-B1 (EP)
Title: Rotary mowers
Inventor: NIEMEYER REINHARD DR
IPC: A01D34/66
Filed: 1996-12-03
Granted: 2001-08-16
Abstract: The mower has at least two mower drums (2,3,4,5) driven in contrary direction, with cutter blades (6) forming autonomous units (10,11,2,13) connected by means of a support (7) to the chassis of the drum mower. The support consists of at least two parallel, spaced apart parts (8,9) joined together by components of the units. The support consists of at least two Z-shaped pieces joined by gears (18) and extra connections (27,28). The gears of the unit parts are connected by cardan shafts (26).
Patent EP-0854319-B1 (EP)
Inventor: FEDDERSEN-CLAUSEN OLIVIER
IPC: F21V11/18
Filed: 1996-12-23
Granted: 2000-06-28
Abstract: The screen consists of a thin plate made of bright white, ceramic material which is transparent and scatters the light. The side of the screening element facing away from the light source has a coating which reflects light and is preferably metal or heat-resistant lacquer. A light-absorbing layer is preferably applied onto the first layer. Between the ceramic and first layer or between the first and second layers is an adhesive layer. The screening element is in the form of a prism or near semicircle.
Patent EP-0823439-B1 (EP)
Inventor: VONGSURAKRAI VARATUS
IPC: C08L3/00
Filed: 1996-08-09
Granted: 2001-01-24
Abstract: Disclosed is an agglomerated, substantially spherical particle comprising 30-95% starch and/or low-protein flour; 0.1-50% silicon dioxide; and 5-15% water, and a method of making the same. <IMAGE>
Patent EP-0752271-B1 (EP)
Inventor: LE LOARER JEAN-LUC
IPC: C08F6/02
Filed: 1996-06-12
Granted: 2000-09-20
Abstract: The process for adsorbing organometallic chelate cpds. comprises contacting the cpds. with an aluminium adsorbent formed by coagulation, extrusion or grinding and having a volume of pores with a dia. greater than 80 Angstrom of 0.15 cm<3>/g and a granular size of less than 4 mm. Also claimed is the aluminium adsorbent comprising an organometallic chelate obtd. after contacting with the organometallic cpd..
Patent EP-0754383-B1 (EP)
Inventor: CHEN WEI
IPC: B01D35/00
Filed: 1996-01-23
Granted: 2011-05-25
Abstract: Ce système de gestion (120) de largeur de bande gère une pluralité de connexions de données virtuelles dans un réseau de télécommunications, et il comprend une entrée (122) destinée à recevoir des cellules mémoire, chaque cellule étant associée à une connexion particulière parmi les connexions virtuelles. Ce système comprend également un regroupement de cellules couplé à l'entrée aux fins de stockage des cellules, des première et seconde files d'attente (126-128) servant à commander les connexions virtuelles, ainsi qu'une sortie (137) destinée à transmettre les cellules à partir du regroupement de cellules. La position relative de la connexion virtuelle dans la première file d'attente est déterminée par une éligibilité variable, laquelle varie en fonction d'une vitesse de transmission des données anticipée et associée à la connexion virtuelle particulière, ainsi qu'en fonction de la quantité de temps pendant lequel cette connexion est restée dans la première file d'attente. La position relative d'une connexion virtuelle dans la seconde file d'attente varie en fonction d'une qualité de service prédéterminée assignée à chacune des connexions virtuelles.
Patent EP-0842500-B1 (EP)
Inventor: HOGL CHRISTIAN
IPC: G07C9/00
Filed: 1996-07-30
Granted: 1999-03-31
Abstract: PCT No. PCT/DE96/01415 Sec. 371 Date Jan. 30, 1998 Sec. 102(e) Date Jan. 30, 1998 PCT Filed Jul. 30, 1996 PCT Pub. No. WO97/05579 PCT Pub. Date Feb. 13, 1997The present invention relates to a locking device 2 for objects of use, which are to be used for a particular period of time by a user, whereby the locking device 2 opens after the input of an opening code 4. The locking device is distinguished in that after input of an end code 6 the locking device issues a confirmation code (8) and changes the opening code in a particular manner (4->4'). Further, the invention relates to a method for the controlled, time-restricted, use of objects of use, which employs the locking device 2. In this method, an opening code 4 is issued by an access control unit 1, the opening code 4 is input into the locking device 2 for opening the same, an end code 6 is input for ending the use and then a confirmation code 8 is issued, the opening code being altered (4->4') by means of the locking device 2.
Patent EP-0869968-B1 (EP)
Inventor: CARPINO PHILIP A
IPC: C07K/
Filed: 1996-12-04
Granted: 2007-05-02
Abstract: L'invention concerne des composés représentés par la formule (I), ainsi que leurs sels acceptables sur le plan pharmaceutique, dans laquelle les substituants sont tels qu'ils sont définis dans la description, qui sont des sécrétagogues de l'hormone de croissance et qui augmentent le niveau de l'hormone de croissance endogène. Ces composés sont utiles pour traiter et prévenir l'ostéoporose, l'insuffisance cardiaque congestive, la fragilité associée au vieillissement, l'obésité, pour accélérer la réparation des fractures osseuses, atténuer la réaction catabolique protéique après une opération lourde, limiter la cachexie et la perte protéique dues à une maladie chronique, accélérer la cicatrisation des lésions ou la covalescence de patients brûlés ou de patients ayant subi une intervention de chirurgie lourde, améliorer la résistance musculaire, la mobilité, le maintien de l'épaisseur de la peau, l'homéostasie métabolique ou l'homéostasie rénale. Ces composés sont également utiles pour traiter l'ostéoporose quand on les utilise en combinaison avec un composé bisphophate, tel qu'alendronate, des oestrogènes, prémarine et, éventuellement, progestérone, un agoniste ou un antagoniste d'oestrogène, ou calcitonine, ainsi qu'avec des compositions pharmaceutiques utiles à cet effet. L'invention concerne, de plus, des compositions pharmaceutiques utiles pour augmenter la production endogène ou la libération d'hormone de croissance chez l'homme ou chez l'animal, et comprenant une dose efficace d'un composé de l'invention et un sécrétagogue d'hormone de croissance sélectionné parmi GHRP-6, Hexareline, GHRP-1, le facteur de libération de l'hormone de croissance (GRF), IGF-1, IGF-2 ou B-HT920. L'invention concerne également des intermédiaires utiles pour préparer les composés représentés par la formule (I).
Patent EP-0803524-B1 (EP)
Inventor: LAAS HANS-JOSEF DR
IPC: C08G18/79
Filed: 1997-04-14
Granted: 2003-11-26
Abstract: Polyurethane powder lacquer contains (A) a binder component with a hydroxyl (OH) number of 25-200 and an average molecular weight of 400-10000 (calculated from the functionality and OH content), which is solid below 40 degrees C and liquid above 130 degrees C; (B) a polyaddition component containing uretdione groups and optionally free isocyanate (NCO) groups based on aliphatic and/or cycloaliphatic diisocyanates, which is solid below 40 degrees C and liquid above 125 degrees C; (C) catalyst containing N,N,N'-tri-substituted amidine structures, which contains 12.0-47.0 wt.% amidine (CN2) groups; optionally (D) other known catalysts; and optionally (E) other usual ancillaries and additives. The mixture contains 0.6-1.4 dimeric NCO (uretdione) and free NCO groups in (B) per OH group in (A) and the amount of (C) is 0.05-5 wt.% of the total amounts of components (A) to (E).
Patent EP-0834271-B1 (EP)
Inventor: HOFMANN THOMAS
IPC: A47C3/026
Filed: 1997-09-10
Granted: 2002-10-30
Abstract: The chair has a support column (14) which has a flange (3) which stretches underneath the seat (2) to the bottom of the front edge of the seat. A first bearing (A) is arranged at the front of the flange. A second bearing (D) is provided at the upper end of the support column in which a connecting rod mounting (4) is rotatably supported. The mounting has an eccentric third bearing (C). A connecting rod (8) is supported in the third bearing and is rigidly connected at an angle with the backrest (1). The connecting rod has a fourth bearing (B) between its connection with the backrest and its joint to the mounting (4). The seat is supported in its rear region in the fourth bearing.
Patent EP-0822186-B1 (EP)
Inventor: BECKETT RAYMOND PAUL
IPC: C07D277/82
Filed: 1995-01-20
Granted: 2000-03-15
Abstract: The novel compound L-tert-leucine-2-pyridylamide is a useful intermediat for the preparation of matrix metalloproteinase inhibitor compounds.
Patent EP-0905868-B1 (EP)
Inventor: YANG TAI-HER
IPC: H02K23/02
Filed: 1997-09-30
Granted: 2008-03-26
Abstract: The low armature reacting X typemagnetic circuit structure of the DC electrical machine is comprised of integrally constructed or assembled X typemagnetic circuit structures in same as the number of the magnetic poles to combine with the neighboring poles to constitute field magnetic flux circuits of two or more than two poles, while under the condition of interference-free field magnetic circuits structure, it is characterized that the armature reacting cross magnetic flux circuit of the DC machine is at high magnetic resistance status to inhibit the cross magnetic flux thereby to improve its commutation effectiveness. <IMAGE>
Patent EP-0886092-B1 (EP)
Inventor: RUIZ JESUS
IPC: G01F11/10
Filed: 1997-06-16
Granted: 2004-01-02
Abstract: A metering valve for the delivery of pasty mediums consists essentially of a valve housing (2) with an inlet opening (3) and an outlet opening (4) and of a flow restrictor (5, 15) movably arranged in the valve housing (2). The flow restrictor (5, 15) is provided with one or more holes (6, 7, 16, 17) for forming a connection (V) between the inlet opening (3) and the outlet opening (4). The hole (6) can be intermittently placed between the inlet opening (3) and the outlet opening (4), so that the effective cross-section between the inlet opening (3) and the outlet opening (4) is reduced. <IMAGE>
Patent EP-0883564-B1 (EP)
Inventor: MANUSCH CHRISTOPH
IPC: B65H75/30
Filed: 1997-02-13
Granted: 2000-05-03
Abstract: PCT No. PCT/EP97/00653 Sec. 371 Date May 12, 1999 Sec. 102(e) Date May 12, 1999 PCT Filed Feb. 13, 1997 PCT Pub. No. WO97/30922 PCT Pub. Date Aug. 28, 1997In a friction coupling for the torque-limiting transmission of force between a core of a coil for winding or unwinding a tape and a rotary support for said core there is a first coupling component with an annular cross-section and a second coupling component taking the form of a moulding, in which the annular coupling component is in frictional engagement at several spaced contact points distributed over its periphery with contact area regions on the moulding, and in which one of the two coupling components is secured to the core of the coil, and the other coupling component is a component of the rotary support. The moulding is rigidly dimensionally stable while the annular first coupling component is made of a flexible material. On the occurrence of a relative movement between the two coupling components, the moulding continually deforms the annual coupling component via the contact points.
Patent EP-1011343-B1 (EP)
Inventor: WESTER INGMAR
IPC: A23L27/60
Filed: 1997-11-03
Granted: 2006-10-04
Abstract: Fatty acid esters, such as the unsaturated fatty acid esters of sterols and/or stanols, are used as a replacement for a portion of the undesirable saturated and  trans -unsaturated fats used as structure giving hardstocks in edible foods such as margarines, mayonnaise, cooking oils, cheeses, butter and shortening. Because of the similarity in the crystallinity and physical properties of the esters to those of the undesirable hardstock fats, the substitution or replacement contributes favourably to the flavor, texture and other sensory properties of the foods. The fatty acid esters comprise at least 70 % of the structure giving hardstock.
Patent EP-1064824-B1 (EP)
Inventor: PINEAU MARTIN
IPC: H04S3/00
Filed: 1997-11-14
Granted: 2002-05-29
Abstract: A post-amplification stereophonic to surround sound decoding circuit is described herein. The decoding circuit includes inputs to be connected to a stereophonic power amplifier to receive a powered amplified stereophonic signal and outputs to be connected to left and right main loudspeakers, to left and right secondary loudspeakers and to a central loudspeaker. The decoding circuit includes secondary channels decoding circuit decoding left and right surround channel signals to be supplied to the left and right secondary loudspeakers, respectively, and a central channel decoding circuit decoding a central channel signal to be supplied to the central loudspeaker. The central channel decoding circuit includes two decoupling capacitors decoupling the left and right signals from the powered amplified stereophonic signal before combining these signals to yield the central channel signal. This decoupling action prevents "bleeding" of the left and right signals that would degrade the stereophonic signal.
Patent EP-0900383-B1 (EP)
Inventor: MORO OSAMU
IPC: G01N33/68
Filed: 1997-04-23
Granted: 2003-03-26
Abstract: This specification relates to the use of peptides having a specific affinity to pituitary adenylate cyclase activating polypeptide (PACAP) receptors, particularly MAX (67 amino acids), NSP (61 amino acids) and M65 (46 amino acids). MAX and NSP act as agonists to PACAP type 1 receptors, and M65 acts as an antagonist to PACAP type 1 receptors.
Patent EP-0959128-B1 (EP)
Inventor: MURASHIMA KOUICHIROU
IPC: C12N15/56
Filed: 1997-07-24
Granted: 2006-08-30
Abstract: A highly active cellulase which is to be preferably employed in eliminating fluffs from cellulose-containing fibers, denier reduction and bleaching denim-dyed cellulose fibers; and a gene thereof. This novel cellulase NCE4 isolated from Humicola insolens is a highly active one usable in treating various cellulose-containing fibers.
Patent EP-0915824-B1 (EP)
Inventor: GUARNIERI DECIMO
IPC: C07C69/017
Filed: 1997-07-23
Granted: 2002-04-03
Abstract: PCT No. PCT/IT97/00184 Sec. 371 Date Aug. 3, 1999 Sec. 102(e) Date Aug. 3, 1999 PCT Filed Jul. 23, 1997 PCT Pub. No. WO98/04512 PCT Pub. Date Feb. 5, 1998New stable derivatives of ubiquinole are described, having general formula (I), along with processes for their production and their pharmaceutical use, in particular in the treatment of intracellular oxidative stress and diseases involving oxidative stress of this kind.
Patent EP-0944828-B1 (EP)
Inventor: KELL MICHAEL
IPC: G01N33/15
Filed: 1997-09-17
Granted: 2004-03-31
Abstract: Quantitative compliance markers and associated methods for monitoring patient compliance with medication prescriptions associated with compliance markers have been found to eliminate the need for specific quantitative relationships for each new drug tested. Such compliance markers and methods for monitoring patient compliance utilize pharmacologically inert substances, namely the weak acids benzodiazepines, or non-metabolizable substances in association with an underlying drug at a measurable dosage, so as to correlate compliance marker concentration with underlying medication concentration to determine amount of actual medication ingested.
Patent EP-0959792-B1 (EP)
Inventor: ZUCHERMAN JAMES F
IPC: A61B17/70
Filed: 1997-12-23
Granted: 2007-11-14
Abstract: A spinal distraction implant alleviates pain associated with spinal stenosis, and facet arthropathy by expanding the volume in the spine canal and/or neural foramen. The implant provides a spinal extension stop while allowing freedom of spinal flexion. The implant comprises: 
a first implant member (22) having an upper surface configured to contact an inferior portion of a first spinous process; and 
a second implant member (24) having a lower surface configured to contact a superior portion of a second spinous process; wherein 
the second implant member is movably coupled to the first implant member such that the upper surface of the first implant member is displaceable away from the lower surface of the second implant member.
Patent EP-0861980-B1 (EP)
Inventor: BOJAN VASILE-ADRIAN
IPC: F04B1/00
Filed: 1998-02-28
Granted: 2004-08-04
Abstract: The pump has a feed and simultaneous conveyor conduit (5), a hydrodynamic fluid media flow control unit (6) for control of the fluid medium in the required direction during the pump phases of "suction" and "delivery". A conveyor conduit (7) is provided to the fluid media forward flow point. A fluid medium feed container (8) ensures that the fluid level to be maintained in it causes the funnel connection of the fluid media flow control unit (6) remains hermetically closed. A combination device can be used for handling solid matter by means of fluid media using the hydrodynamic pump, avoiding the employment of cut-offs and other valves and taps affecting the fluid media flow.
Patent EP-0906758-B1 (EP)
Inventor: RONCUCCI GABRIO
IPC: A61K31/355
Filed: 1998-08-11
Granted: 2011-04-20
Abstract: The present invention refers to zinc-phthalocyanines of general formula (I) <CHEM> to processes for their preparation and to their use as phototherapeutic and photodiagnostic agents as free molecules and as conjugates with macromolecular carrier molecules
Patent EP-0920895-B1 (EP)
Inventor: TER MAAT ALBERT JAN
IPC: B01D19/00
Filed: 1998-12-01
Granted: 2005-06-08
Abstract: A device for degassing water and separating a steam/water mixture into steam and water comprises a vessel (41) having at least one sprayer (4), which is arranged in the top of the vessel, for feeding water which is to be degassed, at least one outlet (6) for gases which have been separated off, a manifold (7) which is arranged in the vessel and has a feed connection (47) for steam, and at least one outlet (11,12) for degassed water. The device furthermore comprises a separating device (2) for separating water and steam. The water which is to be degassed is sprayed, by means of the sprayer (4), as droplets (29) into the vessel, which is also partially filled with at least partially degassed water (30). Via the manifold (7), steam emanating from the separating device (2) is passed through this water. The steam is discharged from the vessel together with gases which have been released from the water and with gases which have been released from the water sprayed by the sprayer, and the degassed water is drained off. The water which has been separated off in the separating device is added to the degassed water in the vessel. That part of the steam separated off in the separating device which is not used for degassing purposes is used as process steam. <IMAGE>